Diligence memo · auto-generated · as of July 2, 2026

Jamaica Cures II, LLC

Jamaica Cures II, LLC looks under-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Jamaica Cures II, LLC operates in Agriculture, based in RENO.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Jamaica Cures II, LLC has raised $325K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $225K on 2019-08-02.

Most recent recorded round closed around 2020-02-07.

Valuation (modeled)modeled

Provath models Jamaica Cures II, LLC at approximately $1.3M (range $63K–$15M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.27× the median modeled value of Pre-Seed Agriculture companies in 2019–2021 (98 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 6 months.

Last raise 6.4 yr ago; this sector typically re-raises about every 11 months.

Silent for over 3× the sector's normal cadence.

The last round was 2.3× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 14% of Agriculture peers (1056 compared).

Modeled value ranks above 10% of those peers.

Closest niche peers: Verdant Sciences International Inc., GreenTree Ag Ventures, LLC, Apex Farms Corp., True Classic Production, LLC, Westbrook Labs, Inc..

Peoplefiled

1 named person on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.